United States · FDA National Drug Code directory

Carbidopa and Levodopa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
67046-1450_2d9454a4-28b2-0579-e063-6394a90ab2db
Product NDC
67046-1450
Form
TABLET
Composition / generic term
Carbidopa and Levodopa
Labeler
Coupler LLC
Marketing category
ANDA
Marketing start / end (source format)
20250207
Source listing expiry
20261231

Source-listed ingredients

  • CARBIDOPA — 25 mg/1
  • LEVODOPA — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BLISTER PACK (67046-1450-3) · 67046-1450-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →